SBIO vs. EIRL ETF Comparison
Comparison of ALPS Medical Breakthroughs ETF (SBIO) to iShares MSCI Ireland Capped ETF (EIRL)
SBIO
ALPS Medical Breakthroughs ETF
SBIO Description
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Grade (RS Rating)
Last Trade
$32.96
Average Daily Volume
13,667
84
EIRL
iShares MSCI Ireland Capped ETF
EIRL Description
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Ireland Investable Market 25/50 Index (the "underlying index"). The fund generally invests at least 80% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index is a free float-adjusted market capitalization-weighted index designed to measure the performance of equity securities listed on stock exchanges in Ireland. Components primarily include consumer staples, industrials and materials companies. The fund is non-diversified.Grade (RS Rating)
Last Trade
$66.55
Average Daily Volume
8,364
5
Performance
| Period | SBIO | EIRL |
|---|---|---|
| 30 Days | -4.69% | -4.18% |
| 60 Days | -4.71% | -2.76% |
| 90 Days | -2.99% | -2.26% |
| 12 Months | 6.55% | 22.41% |
1 Overlapping Holdings
| Symbol | Grade | Weight in SBIO | Weight in EIRL | Overlap | |
|---|---|---|---|---|---|
| GHRS | D | 0.47% | 0.45% | 0.45% |
SBIO Overweight 83 Positions Relative to EIRL
| Symbol | Grade | Weight | |
|---|---|---|---|
| KRYS | B | 3.94% | |
| ALKS | C | 3.1% | |
| MRUS | C | 3.01% | |
| RNA | C | 2.93% | |
| IMVT | D | 2.87% | |
| CRNX | D | 2.59% | |
| CORT | C | 2.52% | |
| DNLI | C | 2.47% | |
| FOLD | C | 2.22% | |
| ACLX | C | 2.18% | |
| XENE | F | 2.13% | |
| ACAD | C | 2.04% | |
| PTCT | D | 2.01% | |
| GERN | B | 1.99% | |
| IDYA | F | 1.96% | |
| AGIO | C | 1.87% | |
| CLDX | F | 1.87% | |
| VCEL | C | 1.72% | |
| NTLA | F | 1.69% | |
| CGON | D | 1.52% | |
| VERA | C | 1.44% | |
| PTGX | B | 1.41% | |
| ZLAB | F | 1.35% | |
| ARVN | F | 1.33% | |
| SNDX | C | 1.3% | |
| MORF | C | 1.29% | |
| GLPG | F | 1.25% | |
| IMCR | D | 1.24% | |
| KROS | F | 1.23% | |
| EWTX | B | 1.23% | |
| AKRO | C | 1.22% | |
| MIRM | B | 1.18% | |
| KURA | D | 1.18% | |
| MNKD | C | 1.09% | |
| RCUS | F | 1.04% | |
| BCRX | B | 0.95% | |
| VRNA | B | 0.94% | |
| DAWN | D | 0.91% | |
| XNCR | F | 0.89% | |
| IRON | C | 0.83% | |
| PRTA | F | 0.83% | |
| FDMT | D | 0.82% | |
| IRWD | F | 0.74% | |
| PHVS | F | 0.73% | |
| TARS | C | 0.72% | |
| LQDA | C | 0.71% | |
| VRDN | F | 0.62% | |
| AUPH | C | 0.61% | |
| COGT | C | 0.61% | |
| SPRY | C | 0.59% | |
| LBPH | B | 0.57% | |
| ETNB | F | 0.56% | |
| ANAB | B | 0.51% | |
| ARCT | F | 0.5% | |
| HLVX | C | 0.5% | |
| PLRX | F | 0.49% | |
| OLMA | D | 0.47% | |
| URGN | C | 0.46% | |
| ERAS | C | 0.45% | |
| FLGT | F | 0.45% | |
| MLYS | C | 0.43% | |
| CELC | B | 0.43% | |
| ITOS | D | 0.42% | |
| YMAB | D | 0.41% | |
| APLT | C | 0.4% | |
| SVRA | C | 0.4% | |
| REPL | C | 0.39% | |
| ALLO | F | 0.38% | |
| ALT | F | 0.34% | |
| ALEC | F | 0.33% | |
| ANNX | D | 0.33% | |
| TBPH | D | 0.31% | |
| CMPS | D | 0.31% | |
| ACIU | C | 0.3% | |
| FULC | F | 0.29% | |
| AURA | F | 0.27% | |
| AVXL | C | 0.27% | |
| VNDA | C | 0.26% | |
| ZNTL | F | 0.23% | |
| INZY | D | 0.21% | |
| ENTA | C | 0.2% | |
| STRO | F | 0.18% | |
| ALDX | F | 0.15% |
SBIO: Top Represented Industries & Keywords
EIRL: Top Represented Industries & Keywords
Compare ETFs
